Sara Sánchez Molina

Sara Sánchez-Molina holds a degree in Chemistry (1999) and Biochemistry (2001) from the University of Barcelona. From early 2002 until late 2006, she carried out her doctoral thesis under the supervision of Dr Marian Martínez Balbás in the Molecular Signalling and Chromatin group at the Institute of Molecular Biology of Barcelona (CSIC). During this period, she studied the role of histone modifications in cellular transformation induced by the Ras oncogene, gaining knowledge in molecular biology and epigenetics of cancer.

In 2007, she joined the Chromatin Dynamics group led by Dr Peter Becker at the Adolf Butenandt Institute of the Ludwig Maximilians University in Munich (Germany), where she was employed as a postdoctoral researcher until 2011. During this time, she focused on elucidating the role of the chromatin remodelling complexes of the ISWI family and their function in signalling DNA damage induced by X-rays, UV, and replicational stress.

As a postdoctoral researcher in 2013, she joined the "Sarcomas and Histiocytosis" group. Within this group, she has developed different lines of research focused on analysing chromatin and the Polycomb complex in Ewing Sarcoma. Additionally, she has introduced the latest genomic technologies in the group to obtain the best resolution to different problems. She is a Research Associate and leads different translational projects that reach therapy from a deep understanding of the deregulation of molecular mechanisms associated with chromatin. Her main goal is to propose new treatments for those patients with Ewing Sarcoma with a worse prognosis. She is a co-director of 4 doctoral theses and has participated in different projects and congresses nationally and internationally.